Sept. 17, 2009 - SEQUENOM, Inc. (Nasdaq: SQNM) announced that the company's first laboratory developed test, the SensiGene(TM) Cystic Fibrosis (CF) Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA (Clinical Laboratory Improvement Amendments, 1988) molecular diagnostic laboratory and a wholly-owned subsidiary of Sequenom, Inc... Sequenom's Press Release -
Nov 3, 2009
Sequenom : Launch of SensiGene Cystic Fibrosis Carrier Screening Test
Sept. 17, 2009 - SEQUENOM, Inc. (Nasdaq: SQNM) announced that the company's first laboratory developed test, the SensiGene(TM) Cystic Fibrosis (CF) Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA (Clinical Laboratory Improvement Amendments, 1988) molecular diagnostic laboratory and a wholly-owned subsidiary of Sequenom, Inc... Sequenom's Press Release -
